Cocaine activation discriminates dopaminergic projections by temporal response: An fMRI study in rat

NeuroImage

Volumn 11, Issue 1, 2000, Pages 13-23

  Marota, John J A ^a   Mandeville, Joseph B ^a   Weisskoff, Robert M ^a   Moskowitz, Michael A ^a   Rosen, Bruce R ^a   Kosofsky, Barry E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN REGION; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; IMAGING SYSTEM; MALE; NEUROCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0033960431     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.1999.0520     Document Type: Article

References (54)

1. Baker D. A., Fuchs R. A., Specio S. E., Khroyan T. V., Neisewander J. L. Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference. Synapse. 30:1998;181-193.
2. Bjorklund A., Lindvall O. Dopamine-containing systems in the CNS. Bjorklund A., Hokfelt T. Handbook of Chemical Neuroanatomy. 1984;55-122 Elsevier, Amsterdam.
3. Booze R. M., Lehner A. F., Wallace D. R., Welch M. A., Mactutus C. F. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats. Neurotoxicol. Teratol. 19:1997;7-15.
4. Breiter H. C., Gollub R. L., Weisskoff R. M., Kennedy D. N., Makris N., Berke J. D., Goodman J. M., Kantor H. L., Gastfriend D. R., Riorden J. P., Mathew R. T., Rosen B. R., Hyman S. E. Acute effects of cocaine on human brain activity and emotion. Neuron. 19:1997;591-611.
5. Fallon J. H., Moore R. Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180:1978;545-580.
6. Fremeau R. T. J., Duncan G. E., Fornaretto M. G., Dearry A., Gingrich J. A., Breese G. R., Caron M. G. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl. Acad. Sci. USA. 88:1991;3772-3776.
7. Gawin F. H. Cocaine addiction: Psychology and neurophysiology. Science. 251:1991;1580-1586.
8. Gold M., Washton A., D. C. Cocaine abuse: Neurochemistry, phenomenology, and treatment. Kozel N. J., Adams E. H. Cocaine Use in America: Epidemiologic and Clinical Perspectives. 1985;130-150 U.S. Govt. Printing Office, Washington.
9. Gollub R. L., Breiter H., Weisskoff R., Kennedy W., Kennedy D., Kantor H., Gastfriend D., Berke J., Riorden J., Mathew T., Makris N., Guimaraes A., Hyman S., Rosen B. Cocaine induced global decrease in cerebral blood flow does not obscure regional activation detected by fMRI. Soc. Neurosci. Abstr. 22:1996;1933.
10. Graybiel A. M., Moratalla R., Robertson H. A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in stiosome-matrix compartments and limbic subdivisions of the striatum. Proc. Nat. Acad. Sci. USA. 87:1990;6912-6916.
11. Hansen T. D., Warner D. S., Todd M. M., Vust L. J. The role of cerebral metabolism in determining the local cerebral blood flow effects of volatile anesthetics: Evidence for persistent flow-metabolism coupling. J. Cereb. Blood Flow Metab. 9:1989;323-328.
12. Hyman S. E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
13. Jones R. C. W., Chou T., Marota J.-J. A., Mandeville J. B., Weisskoff R. M., Moskowitz M., Rosen B., Kosofsky B. E. Dopaminergic influences on cocaine-induced regional brain activation: A 2DG study. Soc. Neurosci. Abstr. 24:1998;778.
14. Jung, C. W., Weissleder, R., Josephson, L., Bengele, H., and Brady, T. J.1996. Physical properties of MION-46 and AMI-227. Int. Soc. Magn. Reson. Med., 4th Annual Meeting, p. 1681.
15. Kennan R. P., Scanley B. E., Innis R. B., Gore J. C. Physiological basis for BOLD MR signal changes due to neuronal stimulation: Separation of blood volume and magnetic susceptibility effects. Magn. Reson. Med. 40:1998;840-846.
16. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
17. Koob G. F., Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science. 278:1997;52-58.
18. Koob G. F., Nestler E. J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9:1997;482-497.
19. Kosofsky B. E., Genova L. M., Hyman S. E. Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J. Comp. Neurol. 351:1995a;27-40.
20. Kosofsky B. E., Genova L. M., Hyman S. E. Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J. Comp. Neurol. 351:1995b;41-50.
21. Le A. D., Tomkins D., Higgins G., Quan B., Sellers E. M. Effects of 5-HT3, D1 and D2 receptor antagonists on ethanol- and cocaine-induced locomotion. Pharmacol. Biochem. Behav. 57:1997;325-332.
22. Lindauer U., Villringer A., Dirnagl U. Characterization of CBF response to somatosensory stimulation: Model and influence of anesthetics. Am. J. Physiol. 264:1993;1223-1228.
23. London E. D., Wilkerson G., Goldberg S. R., Risner M. E. Effects of l-cocaine on local cerebral glucose utilization in the rat. Neurosci. Lett. 68:1986;73-78.
24. London E. D., Wilkerson G., Ori C., Kimes A. S. Central action of psychomotor stimulants on glucose utilization in extrapyramidal motor areas of the rat brain. Brain Res. 512:1990;155-158.
25. Mandeville, J. B., Marota, J. J. A., Keltner, J. R., Kosofsky, B. E., Burke, J., Hyman, S., LaPointe, L., Reese, T., Kwong, K., Rosen, B. R., Weissleder, R., and Weisskoff, R. M.1996. CBV functional imaging in rat brain using iron oxide agent at steady state concentration. Int. Soc. Magn. Reson. Med., 4th Annual Meeting, p. 292.
26. Mandeville J. B., Marota J. J. A., Kosofsky B. E., Keltner J. R., Weissleder R., Rosen B. R., Weisskoff R. M. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 39:1998;615-624.
27. Mandeville J. B., Moore J., Chesler D. A., Garrido L., Weissleder R., Weisskoff R. M. Dynamic liver imaging with iron oxide agents: Effects of size and biodistribution on contrast. Magn. Reson. Med. 37:1997;885-890.
28. Mansour A., Meador-Woodruff J. H., Bunzow J. R., Civelli O., Akil H., Watson S. J. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10:1990;2587-2600.
29. Oades R. D., Halliday G. M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. 434:1987;117-165.
30. Palmer J. T., de Crespigny A. J., Williams S., Busch E., van Bruggen N. High-resolution mapping of discrete representational areas in rat somatosensory cortex using blood volume-dependent functional MRI. NeuroImage. 9:1999;383-392.
31. Papasava M., Oei T. P., Singer G. Low dose cocaine self-administration by naive rats: Effects of body weight and a fixed-time one minute food delivery schedule. Pharmacol. Biochem. Behav. 15:1981;485-488.
32. Papasava M., Singer G. Self-administration of low-dose cocaine by rats at reduced and recovered body weight. Psychopharmacology. 85:1985;419-425.
33. Payen J.-F., Vath A., Koenigsberg B., Bourlier V., Decorps M. Regional cerebral plasma volume response to carbon dioxide using magnetic resonance imaging. Anesthesiology. 88:1998;984-992.
34. Porrino L. J. Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology. 112:1993;343-351.
35. Porrino L. J., Domer F. R., Crane A. M., Sokoloff L. Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacology. 1:1988;109-118.
36. Schaffer B. K., Linker C., Papisov M., Tsai E., Nossiff N., Shibata T., Bogdanov A. Jr., Brady T. J., Weissleder R. MION-ASF: Biokinetics of an MR receptor agent. Magn. Reson. Imag. 11:1993;411-417.
37. Self D. W., Barnhart W. J., Lehman D. A., Nestler E. J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 271:1996;1586-1589.
38. Self D. W., Nestler E. J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
39. Shen T., Weissleder R., Papisov M., Bogdanov A. Jr., Brady T. J. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties. Magn. Reson. Med. 29:1993;599-604.
40. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed. Proc. 40:1981;2311-2316.
41. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;897-916.
42. Stein E., Fuller S. Cocaine's time action profile on regional cerebral blood flow in the rat. Brain Res. 626:1993;117-126.
43. Stein E. A., Fuller S. A. Selective effects of cocaine on regional cerebral blood flow in the rat. J. Pharmacol. Exp. Ther. 262:1992;327-334.
44. Stein E. A., Pankiewicz J., Harsch H. H., Cho J. K., Fuller S. A., Hoffmann R. G., Hawkins M., Rao S. M., Bandettini P. A., Bloom A. S. Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. Am. J. Psychiatry. 155:1998;1009-1015.
45. Steiner H., Gerfen C. R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
46. Steketee J. D., Braswell B. C. Injection of SCH 23390, but not 7-hydroxy-DPAT, into the ventral tegmental area blocks the acute motor-stimulant response to cocaine. Behav. Pharmacol. 8:1997;58-64.
47. Swanson L. W. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;321-353.
48. Trugman J. M., James C. L. D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Res. 607:1993;270-274.
49. Ueki M., Mies G., Hossmann K. Effect of alpha-chloralose, halothane, pentobarbital, and nitrous oxide anesthesia on metabolic coupling in somatosensory cortex of rat. Acta Anaesthesiol. Scand. 36:1992;318-322.
50. van Bruggen N., Busch E., Palmer J. T., Williams S. P., de Crespigny A. J. High-resolution functional magnetic resonance imaging of the rat brain: Mapping changes in cerebral bloodvolume using iron oxide contrast media. J. Cereb. Blood Flow Metab. 18:1998;1178-1183.
51. Wise R. Neurobiology of addiction. Curr. Opin. Neurobiol. 6:1996;243-251.
52. Wise R. A., Rompre P. P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
53. Young S. T., Porrino L. J., Iadarola M. J. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA. 88:1991;1291-1295.
54. Zaharchuk G., Bogdanov A. A. Jr., Marota J. J., Shimizu-Sasamata M., Weisskoff R. M., Kwong K. K., Jenkins B. G., Weissleder R., Rosen B. R. Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): A steady-state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction. Magn. Reson. Med. 40:1998;666-678.